Kidney disease
New drugs
ACCEL-Sevelamer
Medical ingredient:
Sevelamer Carbonate
Indication:
ACCEL-Sevelamer is used for the control of high phosphorus levels in patients with end stage kidney disease undergoing dialysis (whether hemodialysis or peritoneal dialysis).
For more information, see the Regulatory Decision Summary.
New generic drugs
Health Canada approved one new generic drug for kidney disease.
Risk communications
Health Canada released one risk communication on kidney disease.